DEUTSCHE BANK AG\ - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 41 filers reported holding ACER THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$43,000
+72.0%
12,400
-0.5%
0.00%
Q1 2020$25,000
-49.0%
12,466
-0.8%
0.00%
Q4 2019$49,000
+1125.0%
12,568
+855.7%
0.00%
Q3 2019$4,000
-71.4%
1,315
-65.2%
0.00%
Q2 2019$14,000
-93.8%
3,779
-59.6%
0.00%
Q1 2019$226,000
+1312.5%
9,355
+1069.4%
0.00%
Q4 2018$16,0008000.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 143,000$2,877,0002.19%
Vivo Capital, LLC 579,051$11,651,0001.49%
Nantahala Capital Management 903,455$18,178,0000.56%
HEARTLAND ADVISORS INC 220,000$4,426,0000.37%
DRIEHAUS CAPITAL MANAGEMENT LLC 388,712$7,821,0000.34%
Avoro Capital Advisors LLC 150,000$3,018,0000.18%
Monashee Investment Management LLC 11,364$229,0000.16%
EMERALD MUTUAL FUND ADVISERS TRUST 125,000$2,515,0000.12%
ARDSLEY ADVISORY PARTNERS LP 20,000$402,0000.10%
683 Capital Management, LLC 19,367$390,0000.02%
View complete list of ACER THERAPEUTICS INC shareholders